Ustekinumab
Ustekinumab is an active ingredient of the class «immunosuppressive drug».
Pharmaceutical drug
What it is used for
- Plaque psoriasis
- Crohn's disease
- Ulcerative colitis
- Arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Psoriasis
- Immune disorder
Ustekinumab is a human interleukin-12 and -23 antagonist indicated for the treatment of: Moderate to severe plaque psoriasis in adults and pediatric patients 6 years of age and older who are candidates for phototherapy or systemic therapy.
Plaque psoriasis Yesintek is indicated for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate (MTX) or PUVA (psoralen and…
How it works
- Interleukin-12 inhibitor
- Interleukin-23 inhibitor
Class: immunosuppressive drug
Common side effects
The following serious adverse reactions are discussed elsewhere in the label: Infections Malignancies Serious Hypersensitivity Reactions Posterior Reversible Encephalopathy Syndrome (PRES) Noninfectious Pneumonia Most common adverse reactions are: Psoriasis and Psoriatic Arthritis (≥3%): nasopharyngitis, upper…
Who should not take it
Ustekinumab is contraindicated in patients with clinically significant hypersensitivity to any ustekinumab product or to any of the excipients in Ustekinumab.
Pregnancy and breastfeeding
Available data from the Organization of Teratology Information Specialists (OTIS)/MotherToBaby Ustekinumab Pregnancy Registry, published literature and pharmacovigilance in pregnant women have not identified a Ustekinumab-associated risk of major birth…
Brand names
United States
Stelara
European Union
Fymskina · Imuldosa · Otulfi · Stelara · Steqeyma · Usgena · Usrenty · Usymro · Uzpruvo · Wezenla · Yesintek
Canada
Finlius · Finlius I.v. · Imuldosa · Jamteki · Jamteki I.v. · Otulfi · Otulfi I.v. · Pyzchiva I.v. · Stelara · Stelara I.v. · Steqeyma · Wezlana · Wezlana I.v. · Yesintek · Yesintek I.v.
Approval status
- US Food and Drug Administration
- prescription · since 2009
- European Medicines Agency
- authorised · since 2009
- Health Canada
- prescription · marketed
- First approval anywhere
- 2009
Codes
- ATC
- L04AC05
- RxNorm CUI
- 847083
- ChEMBL
- CHEMBL1201835
- UNII
- FU77B4U5Z0
- Wikidata
- Q420305
Frequently asked questions
What is Ustekinumab used for?
Ustekinumab is used for: Plaque psoriasis, Crohn's disease, Ulcerative colitis, Arthritis, Psoriatic arthritis, Ankylosing spondylitis, Psoriasis, and Immune disorder.
What kind of medicine is Ustekinumab?
Ustekinumab is an active ingredient of the class «immunosuppressive drug».
What are the brand names of Ustekinumab?
Brand names of Ustekinumab include Stelara, Fymskina, Imuldosa, Otulfi, Steqeyma, Usgena, Usrenty, and Usymro.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)